Karuna Wongtangman

Karuna Wongtangman

Auto-generated profile, based on publicly available information

Karuna Wongtangman

Department of Anesthesiology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY, USA; Department of Anesthesiology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2023 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
OAOmid Azimaraghi
Omid Azimaraghi
MBMohammad Bilal
Mohammad Bilal
Somchai AmornyotinSomchai Amornyotin
Somchai Amornyotin
MAMustafa Arain
Mustafa Arain
MBMatthias Behrends
Matthias Behrends
MEMatthias Eikermann
Matthias Eikermann
1

17 December 2022 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
OAOmid Azimaraghi
Omid Azimaraghi
EAElena Ahrens
Elena Ahrens
KWKaruna Wongtangman
Karuna Wongtangman
AWAnnika S. Witt
Annika S. Witt
SRSamuel Rupp
Samuel Rupp
MSMaximilian S. Schaefer
Maximilian S. Schaefer

16 February 2022 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
NLNaama Lieberman
Naama Lieberman
ARAndrew Racine
Andrew Racine
SNSingh Nair
Singh Nair
PSPeter Semczuk
Peter Semczuk
OAOmid Azimaraghi
Omid Azimaraghi
KWKaruna Wongtangman
Karuna Wongtangman

17 December 2024 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
ASAiman Suleiman
Aiman Suleiman
KWKaruna Wongtangman
Karuna Wongtangman
MEMatthias Eikermann
Matthias Eikermann
ASAstrid G. Stucke
Astrid G. Stucke

14 April 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
FAFriederike C Althoff
Friederike C Althoff
XXXinling Xu
Xinling Xu
LWLuca J Wachtendorf
Luca J Wachtendorf
DSDenys Shay
Denys Shay
MPMaria Patrocinio
Maria Patrocinio
KWKaruna Wongtangman
Karuna Wongtangman
Objective To assess variability in the intraoperative use of non-depolarising neuromuscular blocking agents (NMBAs) across individual anaesthesia providers, surgeons and hospitals. Design Retrospective observational cohort study. Setting Two major tertiary referral centres, Boston, Massachusetts, USA. Participants 265 537 adult participants undergoing non-cardiac surgery between October 2005 and September 2017. Main outcome measures We analysed the variances in NMBA use across 958 anaesthesia and 623 surgical providers, across anaesthesia provider types (anaesthesia residents, certified registered nurse anaesthetists, attendings) and across hospitals using multivariable-adjusted mixed effects logistic regression. Intraclass correlations (ICC) were calculated to further quantify the variability in NMBA use that was unexplained by other covariates. Procedure-specific subgroup analyses were performed. Results NMBAs were used in 183 242 (69%) surgical cases. Variances in NMBA use were significantly higher among individual surgeons than among anaesthesia providers (variance 1.32 (95% CI 1.06 to 1.60) vs 0.24 (95% CI 0.19 to 0.28), p<0.001). Procedure-specific subgroup analysis of hernia repairs, spine surgeries and mastectomies confirmed our findings: the total variance in NMBA use that was unexplained by the covariate model was higher for surgeons versus anaesthesia providers (ICC 37.0% vs 13.0%, 69.7% vs 25.5%, 69.8% vs 19.5%, respectively; p<0.001). Variances in NMBA use were also partially explained by the anaesthesia provider’s hospital network (Massachusetts General Hospital: variance 0.35 (95% CI 0.27 to 0.43) vs Beth Israel Deaconess Medical Center: 0.15 (95% CI 0.12 to 0.19); p<0.001). Across provider types, surgeons showed the highest variance, and anaesthesia residents showed the lowest variance in NMBA use. Conclusions There is wide variability across individual surgeons and anaesthesia providers and institutions in the use of NMBAs, which could not sufficiently be explained by a large number of patient-related and procedure-related characteristics, but may instead be driven by preference. Surgeons may have a stronger influence on a key aspect of anaesthesia management than anticipated.

5 February 2025 in Anesthesia & Analgesia
Verified
Journal Article
Closed access
NKNuanprae Kitisin
Nuanprae Kitisin
NRNattaya Raykateeraroj
Nattaya Raykateeraroj
NHNattachai Hemtanon
Nattachai Hemtanon
PKPiyawuth Kamtip
Piyawuth Kamtip
NTNapat Thikom
Napat Thikom
KWKaruna Wongtangman
Karuna Wongtangman
BACKGROUND: Low-dose ketamine may have an opioid-sparing effect in critically ill patients but may also predispose them to traumatic memories. We evaluated the effects of low-dose ketamine infusion in the intensive care unit (ICU) on fentanyl consumption and traumatic memories after hospital discharge. METHODS: This randomized, double-blind, controlled trial was conducted at a university-based surgical ICU. 118 adult patients who were admitted to the ICU after noncardiac, nonneuro, nontrauma surgery between March 2019 and May 2021 were randomized to receive ketamine 1.5 µg/kg/min (n = 60) or placebo (n = 58). Fentanyl was given to achieve pain control (10-point numerical rating scale pain score [NRS] < 4) and sedation control (Richmond Agitation and Sedation Scale [RASS] level between −2 and 0). A secondary study was conducted by a telephone interview after ICU discharge using the Thai version of the posttraumatic stress disorder (PTSD) questionnaire to evaluate signs and symptoms of PTSD and traumatic memories to the time spent in the ICU. RESULTS: 24-hour fentanyl consumption was lower in patients who received ketamine compared with placebo (399 µg [95% confidence interval {CI}, 345–454] vs 468 µg [95% CI, 412–523], difference −68 µg; 95% CI, −67 to −69; P = .041); RASS and NRS scores did not differ between the 2 groups. Exploratory effect modification analysis suggested that the opioid-sparing effect of ketamine may be more relevant in patients with intraabdominal surgery (P-for-interaction = 0.012, difference, −177 µg; 95% CI, −204 to −149 µg; P = .001). No acute adverse effects of ketamine were observed. The secondary study included the information from 91 patients from the primary study. Long-term follow-up data was available for 45 patients (23 in the control group, 22 in the ketamine group), and the evaluations were taken 43 ± 8 months after ICU discharge. In this secondary study, ketamine use was associated with a higher incidence of frightening and delusional memories of critical illness and ICU treatment (65% vs 41%, P = .035). CONCLUSIONS: Low-dose ketamine is associated with a small but statistically significant reduction (15%) of postoperative opioid consumption in the ICU. Our secondary study revealed that patients who received low-dose ketamine during fentanyl-based postoperative pain therapy in the ICU recalled more frightening and delusional memories after ICU discharge.